PRESS RELEASE published on 11/10/2025 at 14:01, 11 months 24 days ago Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS) Mainz Biomed N.V. to attend the 38th GARPS Annual Meeting in Germany to showcase its cancer detection solutions and strengthen partnerships with key opinion leaders in gastroenterology ColoAlert Mainz Biomed Cancer Detection Gastroenterology 38th GARPS Annual Meeting
BRIEF published on 10/15/2025 at 15:06, 1 year ago Mainz Biomed participera au sommet Maxim Growth 2025 à New York Investisseurs Mayence Biomed Détection Du Cancer Rencontres Individuelles Sommet Maxim Growth
BRIEF published on 10/15/2025 at 15:06, 1 year ago Mainz Biomed to Join 2025 Maxim Growth Summit in NYC Investors One-on-one Meetings Mainz Biomed Cancer Detection Maxim Growth Summit
PRESS RELEASE published on 10/15/2025 at 15:01, 1 year ago Mainz Biomed to Attend 2025 Maxim Growth Summit Mainz Biomed N.V. to attend 2025 Maxim Growth Summit, featuring industry leaders and discussions on various sectors. Company specializes in cancer early detection Biotechnology Mainz Biomed Cancer Detection Industry Leaders 2025 Maxim Growth Summit
BRIEF published on 10/08/2025 at 15:05, 1 year ago Mainz Biomed obtient des résultats prometteurs dans une étude sur les biomarqueurs du cancer du pancréas Étude De Faisabilité Mayence Biomed Cancer Du Pancréas DÉTECTION PRÉCOCE Étude Des Biomarqueurs
BRIEF published on 10/08/2025 at 15:05, 1 year ago Mainz Biomed Achieves Promising Results in Pancreatic Cancer Biomarker Study Early Detection Feasibility Study Mainz Biomed Pancreatic Cancer Biomarker Study
PRESS RELEASE published on 10/08/2025 at 15:00, 1 year ago Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project Mainz Biomed reports positive topline results from feasibility study of biomarker panel for pancreatic cancer detection, achieving 100% sensitivity and 95% specificity. The study paves the way for a reliable, non-invasive screening test Early Detection Feasibility Study Mainz Biomed Pancreatic Cancer Biomarker Panel
BRIEF published on 09/30/2025 at 14:06, 1 year 1 month ago Mainz Biomed présentera les avancées en matière de dépistage du cancer colorectal Cancer Colorectal Mayence Biomed Diagnostics Basés Sur L'ARN Réunion De L'OME Étude EAArly DETECT
BRIEF published on 09/30/2025 at 14:06, 1 year 1 month ago Mainz Biomed to Showcase Colorectal Cancer Screening Advances Mainz Biomed Colorectal Cancer RNA-based Diagnostics WEO Meeting EAArly DETECT Study
PRESS RELEASE published on 09/30/2025 at 14:01, 1 year 1 month ago Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting Mainz Biomed to present innovative colorectal cancer screening approach at WEO CRC Meeting. Dr. Lena Krammes will discuss RNA-based diagnostics findings for early cancer detection and prevention Mainz Biomed Colorectal Cancer Screening RNA-based Diagnostics WEO CRC Meeting
Published on 11/05/2026 at 13:30, 24 minutes ago Gemdale Gold Reports Strong Metallurgical Test Results at its Pontio Gold Project: Gold Recoveries of +91% and Copper Recoveries up to 87.5%
Published on 11/05/2026 at 13:29, 25 minutes ago Impauer Technologies Announces Official Release of PauerOne V2 Featuring Integrated PauerEarn Rewards Engine
Published on 11/05/2026 at 13:27, 27 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 11/05/2026 at 13:00, 54 minutes ago NOA Lithium Provides Update On 2026 Exploration Campaign
Published on 11/05/2026 at 13:35, 19 minutes ago DeFi Technologies' Subsidiary Valour Launches Eight New Digital Asset ETPs on Spotlight Stock Market, Expanding Access to AI, Institutional Blockchain, DeFi and Community Tokens
Published on 11/05/2026 at 13:15, 39 minutes ago Global Higher Education Forum Highlights Hong Kong’s Strategic Vision as International Talent Hub
Published on 11/05/2026 at 13:05, 49 minutes ago TR-1: Standard Form for Notification of Major Holdings
Published on 11/05/2026 at 13:05, 49 minutes ago Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic
Published on 11/05/2026 at 13:05, 49 minutes ago movement Acquires Technology and IP Assets of Swiss Digital Health Company dacadoo
Published on 11/05/2026 at 10:16, 3 hours 38 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 10:16, 3 hours 38 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/05/2026 at 07:00, 6 hours 54 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %